Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  raloxifene
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 63
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3068A1-400, NCT00418236
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Phase: Phase III
Type: Prevention
Status: Completed
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: NSABP P-2, CDR0000067081, NCT00003906
Cognition in the Study of Tamoxifen and Raloxifene
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 65 and over
Sponsor: Other
Protocol IDs: IA0132, 1R13AG020218-01, N01-AG-1-2106, NCT00687102
Raloxifene in Preventing Breast Cancer in Premenopausal Women
Phase: Phase II
Type: Prevention
Status: Completed
Age: 23 to 47
Sponsor: NCI
Protocol IDs: CDR0000066428, NCI-98-C-0123, MB-402, NCT00019500
Phase II Randomized Study of Exemestane and Raloxifene in Postmenopausal Women With a History of Stage 0 (Ductal Carcinoma in Situ), I, II, or III Breast Cancer Who Have No Clinical Evidence of Disease
Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99017, NCI-G99-1662, NCT00004247
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 98G1, NCI-G00-1710, NCT00004915
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 35 to 70
Sponsor: Other
Protocol IDs: 26970, NCT00723398
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000069229, OHSU-6312, NCI-H02-0086, NCT00031811
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0851, NCI-2009-01700, 07-008912, NCT01050842
Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Completed
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: NSABP-DMP-1, NCT01399359
Start Over